Dan Schoen
Director TTR Franchise, Global Market Access and Pricing at Alnylam Pharmaceuticals | Arlington Heights, Illinois, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Dan Schoen is a seasoned professional with nearly two decades of experience in the biopharmaceutical industry, currently serving as the Director of the TTR Franchise at Alnylam Pharmaceuticals. In this pivotal role, Dan is instrumental in shaping global market access strategies for innovative therapies, particularly focusing on Onpattro and Amvuttra. His expertise lies in developing comprehensive pricing and reimbursement strategies that not only optimize revenue but also ensure that patients have timely access to transformative treatments.
Dan's current projects include the strategic launch of Amvuttra for cardiomyopathy, where he leads efforts to expand franchise indications and enhance market entry. His role requires a deep understanding of market dynamics and regulatory compliance, allowing him to provide critical access insights that inform pipeline development. By collaborating extensively across various functions, Dan ensures that market access considerations are integrated into the overall business strategy, representing the voice of access on the TTR leadership team.
With a strong foundation in strategic planning and budget management, Dan excels in crafting value propositions that resonate with payers and stakeholders. His skills in contract negotiation and profit optimization are vital in navigating the complexities of the biopharmaceutical landscape. As he continues to drive initiatives that enhance patient access and market presence, Dan remains committed to fostering strategic partnerships that align with Alnylam's mission to deliver groundbreaking therapies to those in need.
Director TTR Franchise, Global Market Access and Pricing at Alnylam Pharmaceuticals in June 2022 to Present
Oncology Market Access c-MET Franchise Lead – Global Market Access & Pricing at AbbVie in January 2022 to June 2022
Associate Director, Global Market Access - Lifecycle Strategy Lead, Venetoclax at AbbVie in March 2020 to December 2021
Associate Director, Oncology Pricing - Global Market Access at AbbVie in January 2018 to March 2020
Sr. Manager, Immunology Pricing - Global Market Access at AbbVie in January 2015 to December 2017
Finance Manager, Global Supply Chain at Baxter International Inc. in July 2014 to January 2015
Finance Manager at Abbott in October 2006 to July 2014
Business Development Representative at Bank of America in August 2005 to October 2006
See more
See less
Strategic Market Access
Global Launch Planning
Crisis Management
Leadership
Change Management
Strategic Alliances
Business Development
Positioning (Marketing)
Patient Access Programs
Digital Health
Real World Evidence (RWE)
Pharmacoeconomics
Strategic Partnerships
Clinical Trials
Data-driven Decision Making
Network Building
Policy Analysis
Regulatory Compliance
Regulatory Affairs
Key Opinion Leaders
Value Propositions
Product Lifecycle Management
Strategic Planning
Data Analysis
Forecasting
Budget Management
Market Research
Health Technology Assessment (HTA)
Reimbursement Strategy
Payer Strategy
Health Economics
Contract Negotiation
Commercial Strategy Development
Pricing Governance
Market Segmentation
Stakeholder Management
Competitive Intelligence
Financial Literacy
Profit Optimization
Cross-functional Collaborations
Contracting Strategy
Value Based Pricing
International Reference Pricing
Product Launch
Strategic Pricing
Healthcare Policy Analysis
Cross-functional Team Leadership
Pricing Strategy
See more
See less
Discover more about Alnylam PharmaceuticalsWhat is Dan Schoen email address?
Email Dan Schoen at [email protected] and [email protected]. This email is the most updated Dan Schoen email found in 2026.
What is Dan Schoen phone number?
Dan Schoen phone number is +13123207324.
How to contact Dan Schoen?
To contact Dan Schoen send an email to [email protected] or [email protected]. If you want to call Dan Schoen try calling on +13123207324.
What company does Dan Schoen work for?
Dan Schoen works for Alnylam Pharmaceuticals
What is Dan Schoen's role at Alnylam Pharmaceuticals?
Dan Schoen is Director TTR Franchise, Global Market Access and Pricing
What industry does Dan Schoen work in?
Dan Schoen works in the Biotechnology Research industry.
Dan Schoen Email Addresses
Dan Schoen Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Dan Schoen
Enterprise Field Sales Representative - Google Cloud at Google
Pilot - A319/320/321 at Delta Air Lines
Marketing Project Manager at Wheeler Fleet Solutions
Embodiment Coach and Trainer at ColbyWilk.com
Chief Executive Officer at MISA Imports Inc.
Sr. Director, Business Intelligence, Customer Experience at Charter Communications
Medical Director at Anthem Blue Cross of California
Consumer Capabilities at Optum
WORK at ARCWorks
owner at monarch painting
owner at Steve Sattler Films
Vice President of Programs at Hendricks County Community Foundation
electritian/ helper at foremost electric
Senior Manager, Strategic Partnerships at Doceree
Senior Partner at Borah, Goldstein, Altschuler, Nahins & Goidel, P.C.
Teacher at Los Angeles Unified School District
Manager, Member Services at East Kentucky Power Cooperative
Clothing Buyer at Ina Buying
Teacher at Henrico County Public Schools
Talent Acquisition Supervisor at SGS
Show more
Show less